CervoMed Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 6.00K shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2023-12-31 was 359.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2022-12-31 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 359.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 0.00 shares.
- CervoMed Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | |
| 2026-03-31 | 6.00K shares 10-Q · filed 2026-05-15 | |
| 2023-12-31 | 359.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 359.00 shares 10-K · filed 2024-03-29 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | 0.00 shares 10-K · filed 2024-03-29 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | |
| 2022-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-18 | |
| 2021-06-30 | 0.00 shares 10-Q · filed 2021-11-10 | 0.00 shares derived: sum of 4 quarters · filed 2022-03-18 |
| 2021-03-31 | 0.00 shares 10-Q · filed 2021-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2022-03-18 |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | 0.00 shares 10-K · filed 2022-03-18 |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 0.00 shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2021-08-11 | 0.00 shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-07 | 0.00 shares derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 0.00 shares 10-K · filed 2021-03-17 |
| 2019-09-30 | 0.00 shares 10-Q · filed 2019-11-08 | 0.00 shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | 0.00 shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | 0.00 shares 10-Q · filed 2020-05-11 | 0.00 shares derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | 0.00 shares 10-K · filed 2020-03-17 |
| 2018-09-30 | 0.00 shares 10-Q · filed 2019-11-08 | |
| 2018-06-30 | 0.00 shares 10-Q · filed 2019-08-08 | |
| 2018-03-31 | 0.00 shares 10-Q · filed 2019-05-09 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | |
| 2017-03-31 | 0.00 shares 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |